Financial Services

JetBlue is adding year-round flights to Dallas and Orlando from Fort Lauderdale, sparking new competition and promising more options for Florida travelers.

As media giants face a fragmented ad landscape, Operative's new AOS Services Platform aims to unify linear and digital revenue with an AI-driven core.

Founder Chuck Cohn pours millions more into his ed-tech firm, a bold move that signals deep confidence despite a slumping stock and cautious analysts.

William Healey, a 25-year veteran, takes the helm as IAAO's 2026 President, guiding the future of global property valuation amid technological change.

With surging revenue for its cholesterol drugs and new guideline backing, Esperion outlines its strategy for profitability and pipeline expansion.

Post-merger, Kepler Fusion unveils its strategy for commercializing compact, aneutronic fusion reactors, betting on a distributed 'Power-as-a-Service' model.

As the HYROX fitness race explodes in popularity, MOVATI Athletic has certified all five Ottawa clubs, positioning the city as a hub for hybrid athletes.

Vanadium giant Largo Inc. inks a binding term sheet to sell a decade's worth of byproduct, a move that could boost its finances and green credentials.

With blockbuster sales from VYJUVEK, Krystal Biotech heads to J.P. Morgan with investors eager for news on its global growth and ambitious pipeline.

New AMA codes for PolarityBio's SkinTE signal a strategic step toward commercialization, aiming to ease clinical adoption for chronic wound care.

EZCORP acquires a controlling stake in Founders One, adding 105 pawn stores and signaling a major consolidation in the alternative finance sector.

Vantage Corp finalizes its PJ Marine Singapore acquisition, a strategic move into China's lucrative market despite recent financial headwinds.

China's ETF market had a record 2025, fueled by AI breakthroughs and state support. A look at the boom, the leaders, and the risks ahead.

EMERGE Commerce CEO Ghassan Halazon unveils a new strategy, detailing past growth errors and a multi-year turnaround that pivots the firm to disciplined growth.

New 2025 U-Haul data reveals a sustained migration to southern states like Texas and Florida, while California and New York see a continued exodus.

JE Cleantech rewards shareholders with a hefty dividend from a property sale, but the move raises questions about its long-term strategy and health.

Gyre Therapeutics secures a pivotal conditional approval pathway in China for its novel liver fibrosis drug, offering hope for millions of hepatitis B patients.

As MRAM demand surges in critical sectors, Everspin Technologies prepares to detail its financial health and strategic roadmap at a key investor event.

A new drug could redefine life for polycythemia vera patients, replacing frequent, burdensome blood draws with a simple weekly self-injection.

Tango Therapeutics adds seasoned CFO Sung Lee to its board, a strategic move to guide its lead cancer drug, vopimetostat, through late-stage trials.